Exane Derivatives’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-2,206
| Closed | -$33.5K | – | 682 |
|
|
2018
Q4 | $33.5K | Sell |
2,206
-520
| -19% | -$7.9K | 0.01% | 374 |
|
|
2018
Q3 | $54.6K | Buy |
2,726
+370
| +16% | +$7.42K | 0.01% | 344 |
|
|
2018
Q2 | $47.5K | Buy |
2,356
+431
| +22% | +$8.68K | 0.01% | 361 |
|
|
2018
Q1 | $35.1K | Sell |
1,925
-1,124
| -37% | -$20.5K | 0.01% | 349 |
|
|
2017
Q4 | $40.4K | Sell |
3,049
-12,357
| -80% | -$164K | 0.01% | 320 |
|
|
2017
Q3 | $284K | Sell |
15,406
-5,601
| -27% | -$103K | 0.05% | 156 |
|
|
2017
Q2 | $386K | Buy |
21,007
+3,164
| +18% | +$58.2K | 0.08% | 141 |
|
|
2017
Q1 | $402K | Sell |
17,843
-1,549
| -8% | -$34.9K | 0.09% | 135 |
|
|
2016
Q4 | $675K | Sell |
19,392
-3,271
| -14% | -$114K | 0.13% | 117 |
|
|
2016
Q3 | $555K | Buy |
22,663
+3,000
| +15% | +$73.5K | 0.08% | 135 |
|
|
2016
Q2 | $470K | Buy |
19,663
+272
| +1% | +$6.51K | 0.08% | 132 |
|
|
2016
Q1 | $454K | Buy |
19,391
+5,613
| +41% | +$131K | 0.06% | 125 |
|
|
2015
Q4 | $416K | Buy |
+13,778
| New | +$416K | 0.06% | 113 |
|